comparemela.com
Home
Live Updates
Kura Oncology Inc (KURA) Reports Q3 2023 Financial Results : comparemela.com
Kura Oncology Inc (KURA) Reports Q3 2023 Financial Results
Company's Cash Reserves of $452.6 Million Expected to Fund Operations Until Mid-2026
Related Keywords
Troy Wilson ,
Kura Oncology Inc ,
Company Performance ,
Mirati Therapeutics ,
Kura Oncology ,
Cash Equivalents ,
Iopharmaceutical Company ,
comparemela.com © 2020. All Rights Reserved.